Maddison, Paul
Lipka, Alexander F.
Gozzard, Paul
Sadalage, Girija
Ambrose, Philip A.
Lang, Bethan
Verschuuren, Jan J.
Article History
Received: 9 January 2020
Accepted: 8 June 2020
First Online: 29 June 2020
Competing interests
: The authors Maddison, Lipka, Gozzard, Sadalage and Ambrose declare no competing interests. Dr Lang is a co-applicant and receives royalties on patent application WO/2010/046716 entitled 'Neurological Autoimmune Disorders'. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies.Professor Verschuuren reports involvement in a National Institutes of Health-sponsored thymectomy trial (ClinicalTrials.gov, number NCT00294658), reports a FP7 European MG grant (602420); and is a consultant for Alexion Pharmaceuticals and arGEN-X.